Literature DB >> 27008881

Comparison of BD Max StaphSR and BD Max MRSAXT for Screening of Staphylococcus aureus Clinical Isolates Collected from Hospitals in the United States.

Rodrigo E Mendes1, Amy A Watters2, Paul R Rhomberg2, David J Farrell2, Ronald N Jones2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27008881      PMCID： PMC4879294          DOI： 10.1128/JCM.00374-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  4 in total

1.  High proportion of wrongly identified methicillin-resistant Staphylococcus aureus carriers by use of a rapid commercial PCR assay due to presence of staphylococcal cassette chromosome element lacking the mecA gene.

Authors:  Dominique S Blanc; Patrick Basset; Immaculée Nahimana-Tessemo; Katia Jaton; Gilbert Greub; Giorgio Zanetti
Journal:  J Clin Microbiol       Date:  2010-12-15       Impact factor: 5.948

2.  Evaluation of BD Max StaphSR and BD Max MRSAXT Assays Using ESwab-Collected Specimens.

Authors:  Suzane Silbert; Carly Kubasek; Faris Galambo; Elaine Vendrone; Raymond Widen
Journal:  J Clin Microbiol       Date:  2015-05-27       Impact factor: 5.948

3.  Performance of BD Max StaphSR for Screening of Methicillin-Resistant Staphylococcus aureus Isolates among a Contemporary and Diverse Collection from 146 Institutions Located in Nine U.S. Census Regions: Prevalence of mecA Dropout Mutants.

Authors:  Rodrigo E Mendes; Amy A Watters; Paul R Rhomberg; David J Farrell; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2015-11-04       Impact factor: 5.948

4.  Cost comparison of MRSA screening and management - a decision tree analysis.

Authors:  Andrea Tübbicke; Claudia Hübner; Nils-Olaf Hübner; Christian Wegner; Axel Kramer; Steffen Fleßa
Journal:  BMC Health Serv Res       Date:  2012-12-01       Impact factor: 2.655
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.